Beurs gesloten -
OTC Markets
21:59:05 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
0,0025
USD
|
+66,67%
|
|
0,00%
|
+92,31%
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
25,39
|
72,38
|
40,74
|
22,7
|
41,02
|
3,674
|
Bedrijfswaarde
1 |
32,19
|
57,94
|
24,73
|
11,71
|
35,28
|
0,2623
|
K/w-verhouding
|
-1,13
x
|
-4,25
x
|
-1,39
x
|
-1,19
x
|
-2,19
x
|
-0,16
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,72
x
|
3,37
x
|
2,12
x
|
2,66
x
|
4,61
x
|
0,58
x
|
Bedrijfswaarde/omzet
|
2,18
x
|
2,69
x
|
1,29
x
|
1,37
x
|
3,96
x
|
0,04
x
|
Bedrijfswaarde/EBITDA
|
-1,95
x
|
-3,94
x
|
-1,4
x
|
-0,64
x
|
-1,89
x
|
-0,01
x
|
Bedrijfswaarde/FCF
|
-3,14
x
|
-7,05
x
|
-1,82
x
|
-1,71
x
|
-3,18
x
|
-0,03
x
|
FCF Yield
|
-31,9%
|
-14,2%
|
-54,8%
|
-58,3%
|
-31,5%
|
-3.903%
|
Price to Book
|
-9,24
x
|
3,44
x
|
1,7
x
|
1,72
x
|
3,95
x
|
1,64
x
|
Aantal aandelen (in duizenden)
|
69,5
|
158
|
322
|
395
|
631
|
921
|
Referentieprijs
2 |
365,4
|
457,2
|
126,3
|
57,48
|
65,04
|
3,990
|
Datum van publicatie
|
23/03/18
|
7/03/19
|
25/03/20
|
25/03/21
|
29/03/22
|
30/03/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
14,76
|
21,5
|
19,2
|
8,549
|
8,907
|
6,366
|
EBITDA
1 |
-16,48
|
-14,69
|
-17,7
|
-18,24
|
-18,63
|
-20,24
|
Bedrijfsresultaat (EBIT)
1 |
-17,72
|
-16,16
|
-18,96
|
-19,59
|
-19,35
|
-20,83
|
Operationele Marge
|
-120,08%
|
-75,15%
|
-98,73%
|
-229,1%
|
-217,27%
|
-327,19%
|
Resultaat voor belastingen (EBT)
1 |
-18,96
|
-16,45
|
-19,29
|
-20,86
|
-17,12
|
-21,58
|
Nettowinst (verlies)
1 |
-18,96
|
-16,45
|
-19,3
|
-20,87
|
-17,15
|
-21,59
|
Nettomarge
|
-128,46%
|
-76,52%
|
-100,49%
|
-244,13%
|
-192,49%
|
-339,2%
|
WPA
2 |
-322,0
|
-107,6
|
-91,17
|
-48,16
|
-29,66
|
-24,28
|
Free Cash Flow
1 |
-10,27
|
-8,22
|
-13,56
|
-6,834
|
-11,1
|
-10,24
|
FCF-marge
|
-69,57%
|
-38,22%
|
-70,59%
|
-79,94%
|
-124,66%
|
-160,79%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
23/03/18
|
7/03/19
|
25/03/20
|
25/03/21
|
29/03/22
|
30/03/23
|
Fiscaal tijdperk: december |
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Omzet
1 |
2,583
|
1,435
|
2,074
|
2,52
|
2,877
|
1,184
|
1,492
|
1,251
|
2,439
|
1,033
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-4,023
|
-4,582
|
-4,082
|
-4,23
|
-4,93
|
-6,254
|
-5,677
|
-4,348
|
-4,551
|
-5,013
|
Operationele Marge
|
-155,75%
|
-319,25%
|
-196,8%
|
-167,85%
|
-171,34%
|
-528,01%
|
-380,6%
|
-347,6%
|
-186,55%
|
-485,48%
|
Resultaat voor belastingen (EBT)
1 |
-4,288
|
-4,846
|
-2,599
|
-4,489
|
-5,189
|
-6,497
|
-5,883
|
-4,515
|
-4,689
|
-5,053
|
Nettowinst (verlies)
1 |
-4,29
|
-4,848
|
-2,615
|
-4,491
|
-5,191
|
-6,498
|
-5,888
|
-4,516
|
-4,693
|
-5,055
|
Nettomarge
|
-166,09%
|
-337,83%
|
-126,07%
|
-178,17%
|
-180,44%
|
-548,57%
|
-394,76%
|
-361,04%
|
-192,37%
|
-489,56%
|
WPA
2 |
-10,92
|
-9,600
|
-4,680
|
-7,200
|
-8,280
|
-9,720
|
-6,480
|
-4,920
|
-3,160
|
-2,280
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
25/03/21
|
13/05/21
|
12/08/21
|
10/11/21
|
29/03/22
|
12/05/22
|
11/08/22
|
10/11/22
|
30/03/23
|
10/05/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
6,8
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
14,4
|
16
|
11
|
5,74
|
3,41
|
Hefboom (schuld/ebitda)
|
-0,4128
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10,3
|
-8,22
|
-13,6
|
-6,83
|
-11,1
|
-10,2
|
ROE (netto-inkomsten/eigen vermogen)
|
438%
|
-182%
|
-85,6%
|
-109%
|
-138%
|
-273%
|
ROA (netto-inkomsten/totale activa)
|
-55,8%
|
-31,1%
|
-26,7%
|
-30,5%
|
-36,8%
|
-54%
|
Totale activa
1 |
33,99
|
52,97
|
72,38
|
68,47
|
46,54
|
40,01
|
Nettoactief per aandeel
2 |
-39,50
|
133,0
|
74,30
|
33,40
|
16,40
|
2,440
|
Cashflow per aandeel
2 |
129,0
|
53,10
|
23,60
|
51,70
|
15,20
|
5,520
|
Capex
1 |
1,02
|
0,95
|
1,1
|
0,45
|
0,64
|
0,02
|
Capex/omzet
|
6,91%
|
4,42%
|
5,74%
|
5,31%
|
7,23%
|
0,36%
|
Datum van publicatie
|
23/03/18
|
7/03/19
|
25/03/20
|
25/03/21
|
29/03/22
|
30/03/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +92,31% | 5,54K | | -12,91% | 19,08 mld. | | -46,21% | 2,65 mld. | | +18,15% | 1,87 mld. | | -3,12% | 1,61 mld. | | +23,78% | 1,21 mld. | | -10,69% | 1,02 mld. | | -20,89% | 905 mln. | | -18,10% | 682 mln. | | -7,14% | 716 mln. |
Medisch diagnose- & testmateriaal
|